Ask Warren

Biodyne

314930 · KOSDAQ · ₩314930 · 바이오다인

₩5,890▲ ₩120 (2.08%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩587M₩867M₩3.5B₩859M₩1.8B₩917M₩1.4B₩1.5B
Cost of sales₩380M₩302M₩1.2B₩347M₩607M₩381M₩629M₩674M
Gross profit₩208M₩565M₩2.2B₩513M₩1.2B₩536M₩785M₩845M
Operating income−₩681M−₩403M₩1.5B−₩383M₩299M−₩808M−₩571M−₩425M
Net income−₩478M₩155M₩839M₩117M₩331M−₩435M₩395M−₩534M
Net income to shareholders−₩323M₩155M₩839M₩117M₩331M−₩435M₩395M−₩534M

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩44B₩45B₩45B₩43B₩43B₩44B₩44B₩44B
Current assets₩17B₩19B₩19B₩22B₩21B₩22B₩22B₩22B
Cash and equivalents₩12B₩12B₩13B₩9.7B₩9.3B₩4.5B₩4.8B₩10B
Total liabilities₩379M₩468M₩871M₩774M₩406M₩1B₩1.1B₩1.3B
Current liabilities₩379M₩468M₩871M₩774M₩406M₩1B₩1.1B₩1.3B
Borrowings₩0₩0————₩0₩0
Total equity₩44B₩44B₩44B₩43B₩43B₩43B₩43B₩43B
Shareholders' equity₩44B₩44B₩44B₩43B₩43B₩43B₩43B₩43B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations₩401M−₩985M₩1.5B₩303M−₩798M−₩167M−₩376M₩728M
Capital spending₩988M₩149M₩2.9B₩69M₩220M₩268M₩129M₩194M
Free cash flow−₩587M−₩1.1B−₩1.4B₩234M−₩1B−₩435M−₩505M₩534M

Consolidated where available. Amounts in won.

Also known as: Biodyne / 바이오다인 / 314930 / KRX:314930

Source: KRX statistical information